AETERNUM HEALTH, INC. (AETN) stock: key figures, P/E, revenue and dividend
Information Technology · United States
AETERNUM HEALTH, INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 203,655.00 USD |
| Gross profit | 120,054.00 USD |
| Operating income | -269,274.00 USD |
| EBIT | -269,274.00 USD |
| Net income | -337,094.00 USD |
| Diluted EPS – continuing operations | -0.01 USD |
Full history since 2010, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About AETERNUM HEALTH, INC.
Aeternum Health Inc. develops and commercializes healthcare and longevity-focused products and solutions. It offers a peptide mix in development for longevity and anti-aging, related intellectual property, know-how, and data used for commercialization of longevity-focused healthcare solutions. It serves healthcare and longevity sector. The company sells its products through Internet. It also engages in mining of critical minerals. The company was founded in 2019 and is based in Washington, District Of Columbia.
More stocks
- Scilex Holding Co (SCLX)
- Elme Communities (ELME)
- Purple Innovation, Inc. (PRPL)
- GREYSTONE LOGISTICS, INC. (GLGI)
- Glidelogic Corp. (GDLG)
- Twin Vee PowerCats, Co. (VEEE)
- LianBio (LIANY)
- DataMeds AI, Inc. (MEDS)
- America Great Health (AAGH)
- Sonoma Pharmaceuticals, Inc. (SNOA)
- Silo Pharma, Inc. (SILO)
- Amesite Inc. (AMST)
Not investment advice. All data without warranty, price as of 16.11.2026. Details in the risk notice.